Annual Total Liabilities
$2.76 M
+$628.00 K+29.43%
31 December 2023
Summary:
ZIVO Bioscience annual total liabilities is currently $2.76 million, with the most recent change of +$628.00 thousand (+29.43%) on 31 December 2023. During the last 3 years, it has fallen by -$8.77 million (-76.05%). ZIVO annual total liabilities is now -87.83% below its all-time high of $22.69 million, reached on 31 December 2018.ZIVO Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$2.58 M
-$292.50 K-10.19%
30 September 2024
Summary:
ZIVO Bioscience quarterly total liabilities is currently $2.58 million, with the most recent change of -$292.50 thousand (-10.19%) on 30 September 2024. Over the past year, it has dropped by -$617.40 thousand (-19.32%). ZIVO quarterly total liabilities is now -89.60% below its all-time high of $24.80 million, reached on 31 March 2019.ZIVO Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZIVO Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +29.4% | -19.3% |
| 3 y3 years | -76.0% | -27.4% |
| 5 y5 years | -87.8% | -76.5% |
ZIVO Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -76.0% | +29.4% | -33.1% | +20.9% |
| 5 y | 5 years | -87.8% | +29.4% | -78.6% | +20.9% |
| alltime | all time | -87.8% | -89.6% |
ZIVO Bioscience Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $2.58 M(-10.2%) |
| June 2024 | - | $2.87 M(-6.9%) |
| Mar 2024 | - | $3.09 M(+11.7%) |
| Dec 2023 | $2.76 M(+29.4%) | $2.76 M(-13.6%) |
| Sept 2023 | - | $3.20 M(-17.1%) |
| June 2023 | - | $3.86 M(+34.3%) |
| Mar 2023 | - | $2.87 M(+34.5%) |
| Dec 2022 | $2.13 M(-27.6%) | $2.13 M(-12.8%) |
| Sept 2022 | - | $2.45 M(-14.3%) |
| June 2022 | - | $2.85 M(-8.0%) |
| Mar 2022 | - | $3.10 M(+5.3%) |
| Dec 2021 | $2.95 M(-74.4%) | $2.95 M(-17.0%) |
| Sept 2021 | - | $3.55 M(-5.8%) |
| June 2021 | - | $3.77 M(-68.8%) |
| Mar 2021 | - | $12.07 M(+4.7%) |
| Dec 2020 | $11.53 M(+32.4%) | $11.53 M(+2.8%) |
| Sept 2020 | - | $11.22 M(+9.8%) |
| June 2020 | - | $10.22 M(+9.5%) |
| Mar 2020 | - | $9.33 M(+7.1%) |
| Dec 2019 | $8.71 M(-61.6%) | $8.71 M(-20.6%) |
| Sept 2019 | - | $10.97 M(-2.6%) |
| June 2019 | - | $11.27 M(-54.6%) |
| Mar 2019 | - | $24.80 M(+9.3%) |
| Dec 2018 | $22.69 M(+36.4%) | $22.69 M(+3.9%) |
| Sept 2018 | - | $21.85 M(+11.6%) |
| June 2018 | - | $19.58 M(-12.4%) |
| Mar 2018 | - | $22.35 M(+34.3%) |
| Dec 2017 | $16.64 M(+15.9%) | $16.64 M(-14.5%) |
| Sept 2017 | - | $19.47 M(+16.0%) |
| June 2017 | - | $16.78 M(+1.2%) |
| Mar 2017 | - | $16.57 M(+15.4%) |
| Dec 2016 | $14.36 M(+50.0%) | $14.36 M(+6.2%) |
| Sept 2016 | - | $13.52 M(+20.6%) |
| June 2016 | - | $11.21 M(+7.1%) |
| Mar 2016 | - | $10.47 M(+9.4%) |
| Dec 2015 | $9.57 M(+47.9%) | $9.57 M(+9.1%) |
| Sept 2015 | - | $8.77 M(+8.7%) |
| June 2015 | - | $8.07 M(+7.1%) |
| Mar 2015 | - | $7.54 M(+16.5%) |
| Dec 2014 | $6.47 M(-45.0%) | $6.47 M(-32.8%) |
| Sept 2014 | - | $9.64 M(+47.2%) |
| June 2014 | - | $6.55 M(-1.8%) |
| Mar 2014 | - | $6.67 M(-43.4%) |
| Dec 2013 | $11.77 M(+180.9%) | $11.77 M(-6.2%) |
| Sept 2013 | - | $12.55 M(+37.8%) |
| June 2013 | - | $9.11 M(+78.6%) |
| Mar 2013 | - | $5.10 M(+21.7%) |
| Dec 2012 | $4.19 M | $4.19 M(+17.1%) |
| Sept 2012 | - | $3.58 M(+2.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2012 | - | $3.50 M(+21.8%) |
| Mar 2012 | - | $2.87 M(+15.1%) |
| Dec 2011 | $2.50 M(+93.2%) | $2.50 M(+50.0%) |
| Sept 2011 | - | $1.66 M(+11.3%) |
| June 2011 | - | $1.49 M(+5.3%) |
| Mar 2011 | - | $1.42 M(+9.9%) |
| Dec 2010 | $1.29 M(-69.2%) | $1.29 M(+7.5%) |
| Sept 2010 | - | $1.20 M(+13.8%) |
| June 2010 | - | $1.06 M(-89.7%) |
| Mar 2010 | - | $10.27 M(+145.2%) |
| Dec 2009 | $4.19 M(+338.6%) | $4.19 M(+8.5%) |
| Sept 2009 | - | $3.86 M(+277.1%) |
| June 2009 | - | $1.02 M(+0.7%) |
| Mar 2009 | - | $1.02 M(+6.5%) |
| Dec 2008 | $954.70 K(-7.3%) | $954.70 K(+8.3%) |
| Sept 2008 | - | $881.20 K(+23.0%) |
| June 2008 | - | $716.30 K(+2.1%) |
| Mar 2008 | - | $701.70 K(-31.9%) |
| Dec 2007 | $1.03 M(-10.8%) | $1.03 M(-14.0%) |
| Sept 2007 | - | $1.20 M(+4.6%) |
| June 2007 | - | $1.15 M(-4.3%) |
| Mar 2007 | - | $1.20 M(+3.6%) |
| Dec 2006 | $1.15 M(-7.6%) | $1.15 M(-3.4%) |
| Sept 2006 | - | $1.19 M(-1.1%) |
| June 2006 | - | $1.21 M(+3.1%) |
| Mar 2006 | - | $1.17 M(-6.3%) |
| Dec 2005 | $1.25 M(+8.2%) | $1.25 M(-15.6%) |
| Sept 2005 | - | $1.48 M(-10.3%) |
| June 2005 | - | $1.65 M(+13.4%) |
| Mar 2005 | - | $1.46 M(+26.0%) |
| Dec 2004 | $1.16 M(+2423.4%) | $1.16 M(+90.4%) |
| Sept 2004 | - | $607.00 K(-11.4%) |
| June 2004 | - | $685.30 K(+80.2%) |
| Mar 2004 | - | $380.40 K(+730.6%) |
| Dec 2003 | $45.80 K(>+9900.0%) | $45.80 K(>+9900.0%) |
| Sept 2003 | - | $0.00(0.0%) |
| June 2003 | - | $0.00(0.0%) |
| Mar 2003 | - | $0.00(0.0%) |
| Dec 2002 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2002 | - | $0.00(0.0%) |
| June 2002 | - | $0.00(0.0%) |
| Mar 2002 | - | $0.00(0.0%) |
| Dec 2001 | $0.00(-100.0%) | $0.00(0.0%) |
| Sept 2001 | - | $0.00(0.0%) |
| June 2001 | - | $0.00(0.0%) |
| Mar 2001 | - | $0.00(-100.0%) |
| Dec 2000 | $1600.00 | $1600.00(>+9900.0%) |
| Sept 2000 | - | $0.00(0.0%) |
| June 2000 | - | $0.00 |
FAQ
- What is ZIVO Bioscience annual total liabilities?
- What is the all time high annual total liabilities for ZIVO Bioscience?
- What is ZIVO Bioscience annual total liabilities year-on-year change?
- What is ZIVO Bioscience quarterly total liabilities?
- What is the all time high quarterly total liabilities for ZIVO Bioscience?
- What is ZIVO Bioscience quarterly total liabilities year-on-year change?
What is ZIVO Bioscience annual total liabilities?
The current annual total liabilities of ZIVO is $2.76 M
What is the all time high annual total liabilities for ZIVO Bioscience?
ZIVO Bioscience all-time high annual total liabilities is $22.69 M
What is ZIVO Bioscience annual total liabilities year-on-year change?
Over the past year, ZIVO annual total liabilities has changed by +$628.00 K (+29.43%)
What is ZIVO Bioscience quarterly total liabilities?
The current quarterly total liabilities of ZIVO is $2.58 M
What is the all time high quarterly total liabilities for ZIVO Bioscience?
ZIVO Bioscience all-time high quarterly total liabilities is $24.80 M
What is ZIVO Bioscience quarterly total liabilities year-on-year change?
Over the past year, ZIVO quarterly total liabilities has changed by -$617.40 K (-19.32%)